​

Bruker (BRKR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BRKR Stock Forecast

Bruker (BRKR) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $51.22, with a high of $60.00 and a low of $35.00. This represents a 18.37% increase from the last price of $43.27.

$35 $47 $59 $71 $83 $95 High: $60 Avg: $51.22 Low: $35 Last Closed Price: $43.27

BRKR Stock Rating

Bruker stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (50.00%), 14 Hold (43.75%), 2 Sell (6.25%), and 0 Strong Sell (0.00%).

Buy
Total 32 0 2 14 16 Strong Sell Sell Hold Buy Strong Buy

BRKR Price Target Upside V Benchmarks

TypeNameUpside
StockBruker18.37%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks41.82%

Price Target Trends

1M3M12M
# Anlaysts3720
Avg Price Target$47.67$46.71$48.95
Last Closing Price$43.27$43.27$43.27
Upside/Downside10.17%7.95%13.13%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 262741-14
Apr, 262751-15
Mar, 262751-15
Feb, 262751-15
Jan, 262751-15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 08, 2026Daniel AriasStifel Nicolaus$45.00$43.732.90%4.00%
May 07, 2026UBS$45.00$42.306.38%4.00%
May 07, 2026Luke SergottBarclays$53.00$42.3025.30%22.49%
Feb 13, 2026Evie KosloskyGoldman Sachs$35.00$37.19-5.89%-19.11%
Feb 13, 2026UBS$49.00$36.9932.47%13.24%
Feb 13, 2026Luke SergottBarclays$50.00$37.5133.30%15.55%
Feb 12, 2026Jefferies$50.00$37.5133.30%15.55%
Jan 26, 2026Guggenheim$58.00$49.0318.29%34.04%
Jan 05, 2026Subbu NambiGuggenheim$53.00$49.876.28%22.49%
Dec 15, 2025Brandon CouillardWells Fargo$55.00$45.1321.87%27.11%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 07, 2026Cowen & Co.HoldHoldhold
May 07, 2026UBSNeutralNeutralhold
May 07, 2026CitigroupNeutralNeutralhold
May 07, 2026BarclaysOverweightOverweighthold
Feb 13, 2026Goldman SachsSellSellhold
Feb 13, 2026UBSNeutralNeutralhold
Feb 13, 2026CitigroupNeutralNeutralhold
Feb 13, 2026BarclaysOverweightOverweighthold
Jan 26, 2026GuggenheimBuyBuyhold
Jan 16, 2026CitigroupNeutralNeutralhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.83$2.00$2.92$0.76$-0.15---
Avg Forecast$2.09$2.32$2.55$2.39$2.68$3.04$3.49$3.76
High Forecast$2.12$2.33$2.58$2.40$2.73$3.08$3.55$3.82
Low Forecast$2.06$2.30$2.52$2.38$2.59$2.97$3.41$3.68
Surprise %-12.44%-13.79%14.51%-68.20%-105.60%---

Revenue Forecast

$2B $3B $3B $4B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.42B$2.53B$2.96B$3.37B$3.44B---
Avg Forecast$2.40B$2.50B$2.92B$3.35B$3.56B$3.76B$4.02B$4.19B
High Forecast$2.42B$2.51B$2.95B$3.39B$3.59B$3.78B$4.02B$4.23B
Low Forecast$2.37B$2.48B$2.87B$3.34B$3.54B$3.75B$4.02B$4.11B
Surprise %0.83%1.20%1.66%0.40%-3.48%---

Net Income Forecast

$-50M $80M $210M $340M $470M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$277.10M$296.60M$427.20M$113.10M$-8.60M---
Avg Forecast$215.24M$241.59M$427.20M$351.43M$391.14M$445.47M$512.28M$553.96M
High Forecast$258.29M$289.91M$512.64M$352.90M$401.21M$453.91M$521.99M$562.22M
Low Forecast$172.19M$193.27M$341.76M$349.97M$381.08M$437.03M$502.58M$541.32M
Surprise %28.74%22.77%--67.82%-102.20%---

BRKR Forecast FAQ

Is Bruker stock a buy?

Bruker stock has a consensus rating of Buy, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 14 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Bruker is a favorable investment for most analysts.

What is Bruker's price target?

Bruker's price target, set by 32 Wall Street analysts, averages $51.22 over the next 12 months. The price target range spans from $35 at the low end to $60 at the high end, suggesting a potential 18.37% change from the previous closing price of $43.27.

How does Bruker stock forecast compare to its benchmarks?

Bruker's stock forecast shows a 18.37% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (41.82%).

What is the breakdown of analyst ratings for Bruker over the past three months?

  • May 2026: 14.29% Strong Buy, 50.00% Buy, 28.57% Hold, 7.14% Sell, 0% Strong Sell.
  • April 2026: 13.33% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 0% Strong Sell.
  • March 2026: 13.33% Strong Buy, 46.67% Buy, 33.33% Hold, 6.67% Sell, 0% Strong Sell.

What is Bruker’s EPS forecast?

Bruker's average annual EPS forecast for its fiscal year ending in December 2026 is $3.04, marking a -2126.67% decrease from the reported $-0.15 in 2025. Estimates for the following years are $3.49 in 2027, and $3.76 in 2028.

What is Bruker’s revenue forecast?

Bruker's average annual revenue forecast for its fiscal year ending in December 2026 is $3.76B, reflecting a 9.49% increase from the reported $3.44B in 2025. The forecast for 2027 is $4.02B, and $4.19B for 2028.

What is Bruker’s net income forecast?

Bruker's net income forecast for the fiscal year ending in December 2026 stands at $445.47M, representing a -5279.87% decrease from the reported $-8.6M in 2025. Projections indicate $512.28M in 2027, and $553.96M in 2028.